Association between dipeptidyl peptidase-4 inhibitors and glucagon-like peptide-1 receptor agonists and COVID-19 infection and adverse outcomes: a cohort study by Douglas S Lee, Peter C Austin, Michael E Farkouh, Cynthia A Jackevicius, Jeffrey C Kwong, Bing Yu, Heather Ross, Jiming Fang, Joan Porter, Vladimír Džavík, Alanna Weisman, Andrea S Gershon, Wade Thompson, Jacob A Udell, Clare L Atzema, Laura E Ferreira-Legere, Andrew Ha

Get full text